714-1375

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
714 (USA) · Dr. Clarke
consented 2013-02-26

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild EAR PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-04-04 (study day 38.0); relationship: NONE

mild assessed

Mild EAR PAIN — outcome: RECOVERED/RESOLVED; onset 2013-04-04 (study day 38.0); relationship: NONE

moderate assessed

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-16 (study day 111.0); relationship: PROBABLE

mild assessed

Mild ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-16 (study day 111.0); relationship: PROBABLE

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-29 (study day 93.0); relationship: PROBABLE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-29 (study day 93.0); relationship: PROBABLE

moderate assessed

Moderate SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-03-30 (study day 33.0); relationship: NONE

moderate assessed

Moderate SKIN IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-03-30 (study day 33.0); relationship: NONE

Data queries

No data queries.